CHD9 anticorps (AA 85-190)
-
- Antigène Voir toutes CHD9 Anticorps
- CHD9 (Chromodomain Helicase DNA Binding Protein 9 (CHD9))
-
Épitope
- AA 85-190
-
Reactivité
- Humain
-
Hôte
- Lapin
-
Clonalité
- Polyclonal
-
Conjugué
- Cet anticorp CHD9 est non-conjugé
-
Application
- Western Blotting (WB)
- Séquence
- SFGSPAEHVL SPHSQFNCSP IHPQNQPNGL FPDVSDGSPM WGHQTATTIS NQNGSPFHQQ GHSHSMHQNK SFVAHHDFAL FQANEQQTQC TSLRSQQNRN NLNPGQ
- Réactivité croisée
- Humain, Souris
- Attributs du produit
- Polyclonal Antibodies
- Purification
- Affinity purification
- Immunogène
- Recombinant fusion protein containing a sequence corresponding to amino acids 85-190 of human CHD9 (NP_079410.4).
- Isotype
- IgG
- Top Product
- Discover our top product CHD9 Anticorps primaire
-
-
- Indications d'application
- WB,1:500 - 1:2000
- Commentaires
-
HIGH QUALITY
- Restrictions
- For Research Use only
-
- Format
- Liquid
- Buffer
- PBS with 0.02 % sodium azide,50 % glycerol, pH 7.3.
- Agent conservateur
- Sodium azide
- Précaution d'utilisation
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- Stock
- -20 °C
- Stockage commentaire
- Store at -20°C. Avoid freeze / thaw cycles.
-
- Antigène
- CHD9 (Chromodomain Helicase DNA Binding Protein 9 (CHD9))
- Autre désignation
- CHD9 (CHD9 Produits)
- Sujet
- Acts as a transcriptional coactivator for PPARA and possibly other nuclear receptors. Proposed to be a ATP-dependent chromatin remodeling protein. Has DNA-dependent ATPase activity and binds to A/T-rich DNA. Associates with A/T-rich regulatory regions in promoters of genes that participate in the differentiation of progenitors during osteogenesis (By similarity.,CHD9,AD013,CHD-9,CReMM,KISH2,PRIC320,Epigenetics & Nuclear Signaling,CHD9
- Poids moléculaire
- 324 kDa/326 kDa
- ID gène
- 80205
- UniProt
- Q3L8U1
- Pathways
- Regulation of Lipid Metabolism by PPARalpha
-